Axcella Health Inc.
NASDAQ:AXLA
Overview | Financials
Company Name | Axcella Health Inc. |
Symbol | AXLA |
Currency | USD |
Price | 4.58 |
Market Cap | 0 |
Dividend Yield | 0% |
52-week-range | 4.58 - 4.58 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. William R. Hinshaw Jr. |
Website | https://www.axcellahealth.com |
An error occurred while fetching data.
About Axcella Health Inc.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD